0001127602-21-023102.txt : 20210804 0001127602-21-023102.hdr.sgml : 20210804 20210804181906 ACCESSION NUMBER: 0001127602-21-023102 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210802 FILED AS OF DATE: 20210804 DATE AS OF CHANGE: 20210804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Liddicoat John R CENTRAL INDEX KEY: 0001752060 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 211145539 MAIL ADDRESS: STREET 1: MEDTRONIC PLC STREET 2: 710 MEDTRONIC PKWY, MS LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-08-02 0001613103 Medtronic plc MDT 0001752060 Liddicoat John R MEDTRONIC PLC 710 MEDTRONIC PKWY, MS LC300 MINNEAPOLIS MN 55432 1 EVP & President of Americas Ordinary Shares 2021-08-02 4 F 0 3258 131.31 D 39494 D Ordinary Shares 2021-08-02 4 A 0 3353 0 A 42847 D Stock Option (Right to Buy) 131.26 2021-08-02 4 A 0 28641 0 A 2022-08-02 2031-08-02 Ordinary Shares 28641 28641 D Stock Option (Right to Buy) 131.26 2021-08-02 4 A 0 1085 0 A 2022-08-02 2031-08-02 Ordinary Shares 1085 1085 D Performance Share Units 2021-08-02 4 A 0 8381 0 A Performance Share Units 8381 8381 D This amount has been adjusted to correct a mathematical error in exempt transactions such as dividend reinvestment. This balance increased by 284 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Each performance share unit represents a contingent right to receive one share of Medtronic common stock. The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 8,381 shares will be issued. The actual number of shares to be issued could range from a low of 1,677 at minimum performance to a high of 16,762 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Vests on August 2, 2024. /s/ Thomas L. Osteraas, attorney-in-fact 2021-08-04